PrecisionLife is a pioneering computational biology company changing the way the world predicts, prevents, and treats chronic disease.
We're finding better, more personalized treatment options for patients with unmet medical needs. Our innovative combinatorial approach allows us to uncover the deepest insights into disease biology and achieve mechanistic patient stratification even in the most heterogeneous conditions.
With a vast repository of information and intellectual property spanning over 50 indications, we have developed one of the most extensive pipelines for precision targeted therapies. This wealth of knowledge empowers us to inform and de-risk every stage of biopharma innovation, from initial concept to the clinic, and to find secondary indications for existing drug programs.
To learn more about our groundbreaking work, please visit us at www.precisionlife.com, connect with us on LinkedIn at @PrecisionLifeAI and follow us on Twitter at @PrecisionLifeAI.